Antibiotic Prescription in Critically Ill Patient in Intensive Care Unit of a Tertiary-Level Hospital of a Lower-Middle Income Country
PDF

Keywords

antibiotic
ICU infection
microorganisms
stewardship

Abstract

Background and aims: Antibiotic resistance is a major global health concern, particularly in lower-middle income countries. High burden of infections in intensive care units (ICUs) and empirical use of broad- spectrum antibiotics can contribute to the emergence of multidrug- resistant (MDR) organisms. This study aimed to assess the antibiotic prescription pattern in the ICU of a tertiary-level hospital of central Nepal.
Methods: A descriptive, cross-sectional study was conducted over the period of 6months analyzing the records of 249 patients admitted to the ICU. All patients aged 14 years or above admitted to the ICU for a minimum of 24 hours were included in the study. Data on patient demographics, diagnosis, antibiotic prescriptions, culture results, and sensitivity patterns were collected and analyzed.
Results: Among 249 patients, 142 were male, with a mean age of 63.07±16.84 years. The average length of stay (LOS) in ICU was 8.72±6.99 days. The most common diagnoses were acute exacerbation of chronic obstructive pulmonary disease (19.3%), septic shock (16.1%), and pneumonia (14.9%). Cultures were positive in 96 cases. Respiratory specimens were the most frequent source (74.3%), and Acinetobacter species (49%) was the predominant isolate. Empiric antibiotics were prescribed to 234 (94%) patients, with 85.5% receiving two or more antibiotics.
Conclusions: Empirical antibiotic use is highly prevalent with a significant burden of MDR pathogens, notably Acinetobacter species in our setting. Regular surveillance of antibiotic use and resistance patterns, along with ICU-specific antibiotic protocols, are essential to promote rational antimicrobial use and combat rising resistance in Nepalese healthcare settings.

https://doi.org/10.3126/jnsccm.v2i2.96481
PDF

References

Gandra S, Alvarez-Uria G, Turner P, Joshi J, Limmathurotsakul D, van Doorn HR. Antimicrobial resistance surveillance in low-and middle-income countries: progress and challenges in eight South Asian and Southeast Asian countries. Clin Microbiol Rev. 2020 Sep 16;33(3):10-128.

Esposito S, Leone S. Antimicrobial treatment for Intensive Care Unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007 May 1;29(5):494-500.

Yin M, Tambyah PA, Perencevich EN. Infection, antibiotics, and patient outcomes in the intensive care unit. JAMA. 2020 Apr 21;323(15):1451-2.

Abubakar U, Amir O, Rodríguez-Baño J. Healthcare- associated infections in Africa: a systematic review and meta-analysis of point prevalence studies. J Pharm Policy Pract. 2022 Dec 31;15(1):99.

Kilari VB, Oroszi T. The Misuse of Antibiotics and the Rise of Bacterial Resistance: A Global Concern. Pharmacology & Pharmacy. 2024 Dec 6;15(12):508-23.

Saharman YR, Karuniawati A, Severin JA, Verbrugh HA. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021 Dec;10:1-9.

Boltena MT, Wolde M, Hailu B, et al. Point prevalence of evidence-based antimicrobial use among hospitalized patients in sub-Saharan Africa: a systematic review and meta-analysis. Sci Rep. 2024 Jun 2;14(1):12652.

Marasine NR, Shrestha S, Sankhi S, Paudel N, Gautam A, Poudel A. Antibiotic utilization, sensitivity, and cost in the medical intensive care unit of a tertiary care teaching hospital in Nepal. SAGE Open Med. 2021 Sep;9:20503121211043710.

Baral P, Hann K, Pokhrel B, et al. Annual consumption of parenteral antibiotics in a tertiary hospital of Nepal, 2017–2019: A cross-sectional study. Public Health Action. 2021 Nov 1;11(1):52-7.

Knaus W. APACHE II Score [Internet]. MDCalc. Available from: https://www.mdcalc.com/calc/1868/apache-ii- score

Naved SA, Siddiqui S, Khan FH. APACHE-II score correlation with mortality and length of stay in an intensive care unit. J Coll Physicians Surg Pak. 2011;21(1):4.

Hollingworth S, Kairuz T. Measuring medicine use: Applying ATC/DDD methodology to real-world data. Pharmacy (Basel). 2021 Mar 17;9(1):60.

Alharthi NR, Kenawy G, Eldalo AS. Antibiotics’ prescribing pattern in intensive care unit in Taif, Saudi Arabia. Saudi Journal for Health Sciences. 2019 Jan 1;8(1):47-53.

Williams A, Mathai AS, Phillips AS. Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioallied Sci. 2011 Oct 1;3(4):531-6.

Gedam S, Singh AP, Barmaiya N. Prescribing pattern of antimicrobial agents in intensive care unit of a teaching hospital in Central India. Int J Basic Clin Pharmacol. 2017;6(6):1507-10.

Kayambankadzanja RK, Lihaka M, Barratt-Due A, et al. The use of antibiotics in the intensive care unit of a tertiary hospital in Malawi. BMC Infect Dis. 2020 Dec;20:1-7.

Chatterjee P, Maiti T, Mandal S, Mukhopadhyay O. Evaluation of antibiotics utilization in an intensive and critical care unit of a tertiary care teaching hospital in West Bengal: An observational study. National Journal of Physiology, Pharmacy and Pharmacology. 2022 Nov 1;12(11):1854-.

Priyankara D, Mudalige A, Lokuge M, et al. Antibiotic prescription in critical care units in Sri Lanka: a prospective multi-centre survey. Ceylon Medical Journal. 2024 Sep 19;69(SI3).

Falade IM, Gyampoh GK, Akpamgbo EO, et al. A Comprehensive Review of Effective Patient Safety and Quality Improvement Programs in Healthcare Facilities. Medical Research Archives. 2024 Jul 31;12(7).

Bear D, Macgowan L, Puthucheary Z, et al. Intensive Care Society State of the Art. Journal of the Intensive Care Society. 2019;20(2 Supplement 1):253.

Godman B, Egwuenu A, Haque M, et al. Strategies to improve antimicrobial utilization with a special focus on developing countries. Life (Basel). 2021 Jun 7;11(6):528.

Kakkar AK, Shafiq N, Singh G, et al. Antimicrobial stewardship programs in resource constrained environments: understanding and addressing the need of the systems. Front Public Health. 2020 Apr 28;8:140.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.